BRAF and Miyoshi myopathy: The main oncogenic driver mutations in cutaneous MM are the BRAF (serin/threonine protein kinase) and NRAS (neuroblastoma RAS viral oncogene) mutations, whereas KIT (tyrosine-protein kinase) mutations are predominantly observed in mucosal and acral melanomas.